BACKGROUND: The United States Preventive Services Task Force (USPSTF) recommends screening adults for depression in primary care settings when staff-assisted depression management programs are available. This recommendation, however, is based on evidence from depression management programs conducted with patients already identified as depressed, even though screening is intended to identify depressed patients not already recognized or treated. The objective of this systematic review was to evaluate whether there is evidence from randomized controlled trials (RCTs) that depression screening benefits patients in primary care, using an explicit definition of screening. METHODS: We re-evaluated RCTs included in the 2009 USPSTF evidence review on depression screening, including only trials that compared depression outcomes between screened and non-screened patients and met the following three criteria: determined patient eligibility and randomized prior to screening; excluded patients already diagnosed with a recent episode of depression or already being treated for depression; and provided the same level of depression treatment services to patients identified as depressed in the screening and non-screening trial arms. We also reviewed studies included in a recent Cochrane systematic review, but not the USPSTF review; conducted a focused search to update the USPSTF review; and reviewed trial registries. RESULTS: Of the nine RCTs included in the USPSTF review, four fulfilled none of three criteria for a test of depression screening, four fulfilled one of three criteria, and one fulfilled two of three criteria. There were two additional RCTs included only in the Cochrane review, and each fulfilled one of three criteria. No eligible RCTs were found via the updated review. CONCLUSIONS: The USPSTF recommendation to screen adults for depression in primary care settings when staff-assisted depression management programs are available is not supported by evidence from any RCTs that are directly relevant to the recommendation. The USPSTF should re-evaluate this recommendation. Please see related article: http://www.biomedcentral.com/1741-7015/12/14 REGISTRATION: PROSPERO (#CRD42013004276).
BACKGROUND: The United States Preventive Services Task Force (USPSTF) recommends screening adults for depression in primary care settings when staff-assisted depression management programs are available. This recommendation, however, is based on evidence from depression management programs conducted with patients already identified as depressed, even though screening is intended to identify depressedpatients not already recognized or treated. The objective of this systematic review was to evaluate whether there is evidence from randomized controlled trials (RCTs) that depression screening benefits patients in primary care, using an explicit definition of screening. METHODS: We re-evaluated RCTs included in the 2009 USPSTF evidence review on depression screening, including only trials that compared depression outcomes between screened and non-screened patients and met the following three criteria: determined patient eligibility and randomized prior to screening; excluded patients already diagnosed with a recent episode of depression or already being treated for depression; and provided the same level of depression treatment services to patients identified as depressed in the screening and non-screening trial arms. We also reviewed studies included in a recent Cochrane systematic review, but not the USPSTF review; conducted a focused search to update the USPSTF review; and reviewed trial registries. RESULTS: Of the nine RCTs included in the USPSTF review, four fulfilled none of three criteria for a test of depression screening, four fulfilled one of three criteria, and one fulfilled two of three criteria. There were two additional RCTs included only in the Cochrane review, and each fulfilled one of three criteria. No eligible RCTs were found via the updated review. CONCLUSIONS: The USPSTF recommendation to screen adults for depression in primary care settings when staff-assisted depression management programs are available is not supported by evidence from any RCTs that are directly relevant to the recommendation. The USPSTF should re-evaluate this recommendation. Please see related article: http://www.biomedcentral.com/1741-7015/12/14 REGISTRATION: PROSPERO (#CRD42013004276).
Authors: Margaret Sampson; Kaveh G Shojania; Jessie McGowan; Raymond Daniel; Tamara Rader; Alla E Iansavichene; Jun Ji; Mohammed T Ansari; David Moher Journal: J Clin Epidemiol Date: 2008-02-14 Impact factor: 6.437
Authors: Michel Joffres; Alejandra Jaramillo; James Dickinson; Gabriela Lewin; Kevin Pottie; Elizabeth Shaw; Sarah Connor Gorber; Marcello Tonelli Journal: CMAJ Date: 2013-05-13 Impact factor: 8.262
Authors: Laurence Z Rubenstein; Cathy A Alessi; Karen R Josephson; M Trinidad Hoyl; Judith O Harker; Fern M Pietruszka Journal: J Am Geriatr Soc Date: 2007-02 Impact factor: 5.562
Authors: Irving Kirsch; Brett J Deacon; Tania B Huedo-Medina; Alan Scoboria; Thomas J Moore; Blair T Johnson Journal: PLoS Med Date: 2008-02 Impact factor: 11.069
Authors: Michael S Martin; George A Wells; Anne G Crocker; Beth K Potter; Ian Colman Journal: Int J Methods Psychiatr Res Date: 2017-12-28 Impact factor: 4.035
Authors: Brooke Levis; Andrea Benedetti; Alexander W Levis; John P A Ioannidis; Ian Shrier; Pim Cuijpers; Simon Gilbody; Lorie A Kloda; Dean McMillan; Scott B Patten; Russell J Steele; Roy C Ziegelstein; Charles H Bombardier; Flavia de Lima Osório; Jesse R Fann; Dwenda Gjerdingen; Femke Lamers; Manote Lotrakul; Sonia R Loureiro; Bernd Löwe; Juwita Shaaban; Lesley Stafford; Henk C P M van Weert; Mary A Whooley; Linda S Williams; Karin A Wittkampf; Albert S Yeung; Brett D Thombs Journal: Am J Epidemiol Date: 2017-05-15 Impact factor: 4.897
Authors: Michelle Roseman; Nazanin Saadat; Kira E Riehm; Lorie A Kloda; Jill Boruff; Abel Ickowicz; Franziska Baltzer; Laurence Y Katz; Scott B Patten; Cécile Rousseau; Brett D Thombs Journal: Can J Psychiatry Date: 2017-08-29 Impact factor: 4.356
Authors: Hillary Samples; Elizabeth A Stuart; Brendan Saloner; Colleen L Barry; Ramin Mojtabai Journal: J Gen Intern Med Date: 2019-08-06 Impact factor: 5.128
Authors: Michelle Roseman; Lorie A Kloda; Nazanin Saadat; Kira E Riehm; Abel Ickowicz; Franziska Baltzer; Laurence Y Katz; Scott B Patten; Cécile Rousseau; Brett D Thombs Journal: Can J Psychiatry Date: 2016-07-09 Impact factor: 4.356
Authors: Chen He; Brooke Levis; Kira E Riehm; Nazanin Saadat; Alexander W Levis; Marleine Azar; Danielle B Rice; Ankur Krishnan; Yin Wu; Ying Sun; Mahrukh Imran; Jill Boruff; Pim Cuijpers; Simon Gilbody; John P A Ioannidis; Lorie A Kloda; Dean McMillan; Scott B Patten; Ian Shrier; Roy C Ziegelstein; Dickens H Akena; Bruce Arroll; Liat Ayalon; Hamid R Baradaran; Murray Baron; Anna Beraldi; Charles H Bombardier; Peter Butterworth; Gregory Carter; Marcos Hortes Nisihara Chagas; Juliana C N Chan; Rushina Cholera; Kerrie Clover; Yeates Conwell; Janneke M de Man-van Ginkel; Jesse R Fann; Felix H Fischer; Daniel Fung; Bizu Gelaye; Felicity Goodyear-Smith; Catherine G Greeno; Brian J Hall; Patricia A Harrison; Martin Härter; Ulrich Hegerl; Leanne Hides; Stevan E Hobfoll; Marie Hudson; Thomas N Hyphantis; Masatoshi Inagaki; Khalida Ismail; Nathalie Jetté; Mohammad E Khamseh; Kim M Kiely; Yunxin Kwan; Femke Lamers; Shen-Ing Liu; Manote Lotrakul; Sonia R Loureiro; Bernd Löwe; Laura Marsh; Anthony McGuire; Sherina Mohd-Sidik; Tiago N Munhoz; Kumiko Muramatsu; Flávia L Osório; Vikram Patel; Brian W Pence; Philippe Persoons; Angelo Picardi; Katrin Reuter; Alasdair G Rooney; Iná S da Silva Dos Santos; Juwita Shaaban; Abbey Sidebottom; Adam Simning; Lesley Stafford; Sharon Sung; Pei Lin Lynnette Tan; Alyna Turner; Henk C P M van Weert; Jennifer White; Mary A Whooley; Kirsty Winkley; Mitsuhiko Yamada; Brett D Thombs; Andrea Benedetti Journal: Psychother Psychosom Date: 2019-10-08 Impact factor: 25.617